Download PDF
Horm Metab Res 2006; 38(10): 631-638
DOI: 10.1055/s-2006-954580
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Subcutaneous Fat Modulates Insulin Sensitivity in Mice by Regulating TNF-α Expression in Visceral Fat

K. Ishikawa 1 , K. Takahashi 1 , H. Bujo 2 , N. Hashimoto 3 , K. Yagui 1 , Y. Saito 1
  • 1Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
  • 2Department of Genome Research and Clinical Application, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
  • 3Division of Applied Translational Research, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Further Information

Publication History

Received 6 March 2006

Accepted after revision 2 May 2006

Publication Date:
30 October 2006 (online)

Also available at
    Permissions and Reprints

Abstract

The distribution of fat in obese persons is related to the risk of developing various metabolic disorders, such as glucose intolerance, dyslipidemia and hypertension, and the combination of these conditions is known as the metabolic syndrome. The aim of this study was to investigate the role of subcutaneous fat in regulating insulin resistance and its influence on TNF-α expression in visceral fat, by using mice that were subjected to subcutaneous lipectomy with or without subsequent fat transplantation. After partial subcutaneous lipectomy, mice showed significantly greater accumulation of visceral fat compared with sham-operated control mice. Lipectomy led to higher plasma insulin and lower plasma glucose levels after loading with glucose and insulin, respectively, compared with the levels in control mice. Insulin-induced phosphorylation of IRS-1 was decreased in the skeletal muscles of lipectomized mice. Subcutaneous transplantation of fat pads into lipectomized mice reversed the above-mentioned changes indicating insulin resistance in these animals. The fat storage area of adipocytes and TNF- α expression by adipocytes in visceral fat were significantly higher in the lipectomized mice than in controls, while subcutaneous transplantation of fat reduced both the fat storage area and TNF-α expression. The insulin resistance of lipectomized mice was also ameliorated by systemic neutralization of TNF-α activity using a specific antibody. These findings obtained in mice subjected to subcutaneous lipectomy with/without subsequent fat transplantation indicate that subcutaneous fat regulates systemic insulin sensitivity, possibly through altering fat storage and the expression of TNF-α by adipocytes in visceral fat. The balance between accumulation of subcutaneous fat and visceral fat may be important with respect to the occurrence of systemic insulin resistance in the metabolic syndrome.

Key words

Lipectomy - TNF-α - subcutaneous - visceral - insulin resistance

References

  • 1 Reaven GM. Role of insulin resistance in human disease (Banting lecture).  Diabetes. 1998;  37 1595-1607
    CrossrefPubMedGoogle Scholar
  • 2 Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults . Executive summery of the Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults.  JAMA. 2001;  285 2486-2497
    CrossrefPubMedGoogle Scholar
  • 3 Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity.  J Clin Endocrinol Metab. 1982;  54 254-260
    CrossrefPubMedGoogle Scholar
  • 4 Tokunaga K, Matsuzawa Y, Ishikawa K. A novel technique for the determination of body fat by computed tomography.  Int J Obes. 1983;  7 437-745
    PubMedGoogle Scholar
  • 5 Hodge AM, Dowse GK, Zimmet PZ. Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans.  Int J Obes Relat Metab Disord. 1993;  17 399-407
    PubMedGoogle Scholar
  • 6 Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, Murayama H, Ohshima H, Shinomiya M, Shirai K, Saito Y, Yoshida S, Saisho H, Ohto M. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen.  Am J Med. 1993;  95 309-314
    CrossrefPubMedGoogle Scholar
  • 7 Matsuzawa Y. Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience.  Diabetes Metab Rev. 1997;  13 3-13
    PubMedGoogle Scholar
  • 8 Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.  Diabetes. 1996;  45 988-991
    PubMedGoogle Scholar
  • 9 Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.  Nat Med. 2002;  8 731-737
    CrossrefPubMedGoogle Scholar
  • 10 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
    CrossrefPubMedGoogle Scholar
  • 11 Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.  Science. 2005;  307 426-430
    CrossrefPubMedGoogle Scholar
  • 12 Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
    CrossrefPubMedGoogle Scholar
  • 13 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose expression of tumor necrosis factor-a in human obesity and insulin resistance.  J Clin Invest. 1995;  95 2409-2415
    CrossrefPubMedGoogle Scholar
  • 14 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase.  J Clin Invest. 1995;  95 2111-2119
    CrossrefPubMedGoogle Scholar
  • 15 Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, Katsilambros N. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.  Metabolism. 1999;  48 1332-1335
    CrossrefPubMedGoogle Scholar
  • 16 Shibasaki M, Takahashi K, Itou T, Miyazawa S, Ito M, Kobayashi J, Bujo H, Saito Y. Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-α?.  Diabetologia. 2002;  45 518-526
    PubMedGoogle Scholar
  • 17 Li Y, Bujo H, Takahashi K, Shibasaki M, Zhu Y, Yoshida Y, Otsuka Y, Hashimoto N, Saito Y. Visceral fat: Higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat.  Exp Biol Med. 2003;  228 1118-1123
    PubMedGoogle Scholar
  • 18 Mauer MM, Harris RB, Bartness TJ. The regulation of total body fat: lessons learned from lipectomy studies.  Neurosci Biobehav Rev. 2001;  25 15-28
    PubMedGoogle Scholar
  • 19 Harris RB, Hausman DB, Bartness TJ. Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes.  Am J Physiol Regul Integr Comp Physiol. 2002;  283 R1094-R1103
    PubMedGoogle Scholar
  • 20 Gabriely I, Barzilai N. Surgical removal of visceral adipose tissue: effects on insulin action.  Curr Diab Rep. 2003;  3 201-206
    PubMedGoogle Scholar
  • 21 Weber RV, Buckley MC, Fried SK, Kral JG. Subcutaneous lipectomy causes a metabolic syndrome in hamsters.  Am J Physiol Regul Integr Comp Physiol. 2000;  279 R936-R943
    PubMedGoogle Scholar
  • 22 Foster DW. The lipodystrophies and other rare disorders of adipose tissue. In: Isselbacher KJ, Eds. Harrison's principles of internal medicine. New York, McGraw-Hill, NY 1994: 2131-2136
    Google Scholar
  • 23 Car A. Toxicity of antiretroviral therapy and implications for drug development.  Nat Rev Drug Discov. 2003;  3 624-634
    PubMedGoogle Scholar
  • 24 Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD. Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group . Combination antiretroviral therapy and the risk of myocardial infarction.  N Engl J Med. 2003;  349 1993-2003
    CrossrefPubMedGoogle Scholar
  • 25 Shibasaki M, Takahashi K, Itou T, Bujo H, Saito Y. A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice.  Biochem Biophys Res Commun. 2003;  309 419-424
    CrossrefPubMedGoogle Scholar
  • 26 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene.  Science. 1995;  269 543-546
    CrossrefPubMedGoogle Scholar
  • 27 Borst SE, Conover CF, Bagby GJ. Association of resistin with visceral fat and muscle insulin resistance.  Cytokine. 2005;  32 39-44
    CrossrefPubMedGoogle Scholar
  • 28 Arioglu E, Duncan-Morin J, Sebring N, Rother KI, Gottlieb N, Lieberman J, Herion D, Kleiner DE, Reynolds J, Premkumar A, Sumner AE, Hoofnagle J, Reitman ML, Taylor SI. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.  Ann Intern Med. 2000;  133 263-274
    PubMedGoogle Scholar
  • 29 D'Andrea F, Grella R, Rizzo MR, Grella E, Grella R, Nicoletti G, Barbieri M, Paolisso G. Changing the metabolic profile by large-volume liposuction: a clinical study conducted with 123 obese women.  Aesthetic Plast Surg. 2005;  29 472-478
    CrossrefPubMedGoogle Scholar
  • 30 Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with large-volume liposuction: a pilot study.  Plast Reconstr Surg. 2001;  108 510-519
    PubMedGoogle Scholar
  • 31 Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.  N Engl J Med. 2004;  350 2549-2557
    CrossrefPubMedGoogle Scholar
  • 32 Borst SE. The role of TNF-alpha in insulin resistance.  Endocrine. 2004;  23 177-182
    CrossrefPubMedGoogle Scholar
  • 33 Borst SE, Lee Y, Conover CF, Shek EW, Bagby GJ. Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue.  Am J Physiol Endocrinol Metab. 2004;  287 E934-E938
    CrossrefPubMedGoogle Scholar
  • 34 Ajuwon KM, Spurlock ME. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.  J Nutr. 2005;  135 1841-1846
    PubMedGoogle Scholar
  • 35 Boucher J, Castan-Laurell I, Daviaud D, Guigne C, Buleon M, Carpene C, Saulnier-Blache JS, Valet P. Adipokine expression profile in adipocytes of different mouse models of obesity.  Horm Metab Res. 2005;  37 761-767
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Yang G, Li L, Fang C, Zhang L, Li Q, Tang Y, Boden G. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats.  Metabolism. 2005;  54 1142-1146
    CrossrefPubMedGoogle Scholar

Correspondence

Hideaki Bujo

Department of Genome Research and Clinical Application (M6)·Graduate School of Medicine·Chiba University

1-8-1 Inohana, Chuo-ku

Chiba 260-8670

Japan

Phone: +81/43/222 71 71, ext. 52 57

Fax: +81/43/226 20 95

Email: hbujo@faculty.chiba-u.jp